Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Comment by Seraphim1on Dec 17, 2016 9:06pm
167 Views
Post# 25615466

RE:RE:Price drop

RE:RE:Price drop
Smarthoney wrote: Yes!
On paper Emblem has a value of 0.60 cents; with intangible value at around 0.80-0.90 cents; the prospects for long term investment are great but the smart money would want to be with companies that reflect CGC and OGI for good reason; they have ideal filing parameters and they make money.
In comparison Beleave is worth more on its well connected culture and its potential once it has LP status; I would suggest to the average retailer if they can not stomach the %40 -%50 drops to follow you will want to dump your shares and consider an LP or lottery tickets closer to inspection like Vodis or pharmaceutical oriented growers like Beleave.
In condlusion do your own research.
This is a billion dollar industry that is looking like the beer and vodka market more than a commodity market and that means smaller outliers have the prospect to make more money for investors if the quality of the brand is strong and celebrity endorsement is behind it. No offence to the management of EMC but they are inovative nerds with no colorful interest in helping investors make comparable margins to their investment. For example BE shares are held tightly.
GLTA



Nonsense, small outliers, and celebrity endorsements is great but more like fluff.  As the ceo of CGC stated on BNN this past week..... " the real winners will not be growers, anyone can grow weed....the winners will be innovators that can deliver in accepted ways" this is where EMC is going to blow everyone out. They are working on acceptable delivery systems that are measurable and targeting specific diseases with slow release technology that physicians will be comfortable prescribing. Diseases like epilepsy, MS, Nausea for cancer patients, chronic pain etc. So fast forward to 2017-18. Do you think that Sun Life  and other insurers will be reimbursing for purchase of edibles like cookies,  wines and joints ? No way! But they will eventually be reimbursing prescription medications delivered in pill format . And in the end that is the ultimate goal of EMC.....acceptance by all parties in this industry.
<< Previous
Bullboard Posts
Next >>